Literature DB >> 421850

Pharmacokinetics of pindolol in Africans.

L A Salako, A Ragon, R A Adio, A O Falase.   

Abstract

The pharmacokinetics of pindolol were determined in 12 hypertensive African subjects after a single oral dose of the drug. The estimated pharmacokinetic parameters do not differ significantly in Africans from the values which have been obtained in other races.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 421850     DOI： 10.1007/bf01920646

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  3 in total

1.  Pharmacokinetics and hepatic extraction ratio of pindolol in hypertensive patients with normal and impaired renal function.

Authors:  D Lavene; Y A Weiss; M E Safar; Y Loria; N Agorus; D Georges; P L Milliez
Journal:  J Clin Pharmacol       Date:  1977 Aug-Sep       Impact factor: 3.126

2.  Pharmacokinetics of unlabelled and 14C-labelled pindolol in uraemia.

Authors:  E E Ohnhaus; E Nüesch; J Meier; F Kalberer
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

3.  A method for the fluorimetric determination of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB46), a beta-blocking agent, in plasma and urine.

Authors:  W L Pacha
Journal:  Experientia       Date:  1969-08-15
  3 in total
  2 in total

1.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

Review 2.  FIRST REPORTS OF CLINICAL PHARMACOKINETICS IN NIGERIA.

Authors:  O S Michael
Journal:  Ann Ib Postgrad Med       Date:  2015-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.